Atrial fibrillation will now be included as a common side effect in the Summary of Product Characteristics for medicinal products containing omega-3-acid ethyl esters.
Primary care physicians should be on the lookout for recurrent arrhythmias after a new study finds that among 1 in 3 patients, AF recurs after discharge from the hospital.
The quest for an anticoagulant that can prevent cardiovascular events without bleeding is something of a holy grail in cardiovascular medicine. Could factor XI inhibitors be the long-sought answer?
Repurposing mirabegron, a drug used to treat overactive bladder disease, did not significantly change left ventricular mass index or diastolic function in pre–heart failure structural heart disease.